Results 191 to 200 of about 212,526 (280)

Novel Disubstituted Pyrimidines as Inhibitors of Bruton’s Tyrosine Kinase

, 2014
Gérard Rossé
openalex   +1 more source

HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis [PDF]

, 2016
Jin Kyun Park, Joo‐Yun Byun, Ji Ah Park, Yu-Yon Kim, Ye Ji Lee, Jeong In Oh, Sun Young Jang, Young‐Hoon Kim, Yeong Wook Song, Jeewoong Son, Kwee Hyun Suh, Young Mi Lee, Eun Bong Lee   +12 more
openalex   +1 more source

Next-generation Bruton's tyrosine kinase inhibitors for chronic lymphocytic leukemia-associated membranoproliferative glomerulonephritis: a case report. [PDF]

Ann Hematol
Chen L, Huang Y, Xu J, Huang S, Zhang Q, Hua F, Pan X, Mi JQ.   +7 more
europepmc   +1 more source

Phase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies

, 2018
Wojciech Jurczak, Simon Rule, William Townsend, David Tucker, Barbara Sarholz, J. Scheele, John G. Gribben, Pier Luigi Zinzani   +7 more
openalex   +1 more source

Cryptococcal Infection in a Patient With Chronic Lymphocytic Leukaemia Receiving Acalabrutinib, a Bruton's Tyrosine Kinase Inhibitor: A Case Report. [PDF]

Cureus
Al-Shaker AN, Agarwal A, Saeed MT, Marney Z.   +3 more
europepmc   +1 more source

The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton’s Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions

, 2021
Iván Parra‐Izquierdo, Hari Hara Sudhan Lakshmanan, Alexander R. Melrose, Jiaqing Pang, Tony J. Zheng, Kelley R. Jordan, Stéphanie E. Reitsma, Owen J. T. McCarty, Joseph E. Aslan   +8 more
openalex   +1 more source

Mechanisms of resistance to bruton's tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways. [PDF]

Ann Hematol
Dong X, Tang S, Chen M, Chen Q, Wang Y, Shi Y, Deng Y, Chen Y, He Z, Yu L, Wang C.   +10 more
europepmc   +1 more source

BAP-135, a target for Bruton’s tyrosine kinase in response to B cell receptor engagement

, 1997
Weiyi Yang, Stephen Desiderio
openalex   +1 more source

Correction to "Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures". [PDF]

ACS Pharmacol Transl Sci
Darragh AC, Hanna AM, Lipner J, King AJ, Servant NB, Jahic M.   +5 more
europepmc   +1 more source

Delayed Cutaneous Ecchymosis with Bruton's Tyrosine Kinase Inhibitors and Breast Radiation: A Case Report. [PDF]

Adv Radiat Oncol
Kim J, Adrianzen Herrera D, Li PC.
europepmc   +1 more source